Colon and Rectum Carcinoma Surveillance Counterpoint: Japan
Purchase on Springer.com
$29.95 / €24.95 / £19.95*
* Final gross prices may vary according to local VAT.
The primary aim of surveillance after curative resection of colorectal cancer is to detect metastasis, local recurrence, or metachronous primary cancers at an early stage when curative reoperations are possible, leading to improvement of the prognosis. Recent meta-analyses show that more intensive postoperative surveillance results in a reduction of mortality and an improvement in the curative reoperation rate in comparison to minimal surveillance [1-6]. Furthermore, the early detection of recurrence of colorectal cancer also results in prolongation of life by chemotherapy and/or radiotherapy, even in patients with unresectable disease . While several recommendations are now available from the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO) and so on [8,9], the best strategy for the surveillance still remains controversial.
- Rosen M, Chan L, Beart Jr RW, et al. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum. 1998;41:1116–26. CrossRef
- Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26. CrossRef
- Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2002:CD002200.
- Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow-up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. Br Med J. 2002;324:813–6. CrossRef
- Renehan AG, O’Dwyer ST, Whynes DK. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. Br Med J. 2004;328:81–4. CrossRef
- Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum. 2007;50:1783–99. CrossRef
- McArdle C. ABC of colorectal cancer: effectiveness of follow up. Br Med J. 2000;21:1332–5. CrossRef
- Desch CE, Benson III AB, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005;23:8512–9. CrossRef
- Van Cutsem EJ. Colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2007; 18 Suppl 2:ii21-2.
- Kobayashi H, Mochizuki H, Sugihara K, et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery. 2007;141:67–75. CrossRef
- The Japanese Society for Cancer of the Colon and Rectum. JSCCR guidelines 2010 for the treatment of colorectal cancer. (In Japanese) Tokyo, Kanehara; 2010; 36.
- Ratto C, Sofo L, Ippoliti M, et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum. 1999;42:143–54. CrossRef
- Gan S, Wilson K, Hollington P. Surveillance of patients following surgery with curative intent for colorectal cancer. World J Gastroenterol. 2007;13:3816–23.
- Miles K, Burkill G. Colorectal cancer: imaging surveillance following resection of primary tumour. Cancer Imaging. 2007;7:S143–149. CrossRef
- Pietra N, Sarli L, Costi R, et al. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum. 1998;41:1127–33. CrossRef
- Schaefer O, Langer M. Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol. 2007;17:2044–54. CrossRef
- Colon and Rectum Carcinoma Surveillance Counterpoint: Japan
- Book Title
- Patient Surveillance After Cancer Treatment
- pp 195-198
- Print ISBN
- Online ISBN
- Series Title
- Current Clinical Oncology
- Humana Press
- Copyright Holder
- Springer Science+Business Media New York
- Additional Links
- Industry Sectors
- eBook Packages
- Editor Affiliations
- ID1. Department of Surgery, Saint Louis University
- ID2. Fac. Medicine, Dept. Surgery II, Kyushu University
- ID3. BC Cancer Agency
- ID4. School of Medicine, Washington University
- ID5. St Helens Teaching Hospital, University of Liverpool
- ID6. Sydney Cancer Centre, Sydney Melanoma Unit, Royal Prince Alfred Hospital
- ID7. Saint Louis University Medical Center
- ID8. Dana-Farber Cancer Institute, Harvard Medical School
- ID9. International Atlantic Economic Society
- Author Affiliations
- 00351. Department of Gastroenterological Surgery, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan
To view the rest of this content please follow the download PDF link above.